Researchers find new protein 41B that can be used as a drug target for COVID-19 treatment
firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.
Studies reveal potential weaknesses in SARS-CoV-2 infection — Agenparl
agenparl.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from agenparl.eu Daily Mail and Mail on Sunday newspapers.
Studies reveal potential weaknesses in SARS-CoV-2 infection
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Study: TMEM41B transmembrane protein is a critical factor for SARS-CoV-2 replication
A single protein that appears necessary for the COVID-19 virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.
The molecule, known as transmembrane protein 41 B (TMEM41B), is believed to help shape the fatty outer membrane that protects the virus genetic material while it replicates inside an infected cell and before it infects another.
The latest finding comes from a pair of studies led by researchers at NYU Grossman School of Medicine and NYU Langone Health s Perlmutter Cancer Center, and colleagues at Rockefeller University and elsewhere.